LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 300 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.62 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $618,000 | -30.2% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $886,000 | +4.7% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $846,000 | -12.8% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $970,000 | -9.3% | 8,500 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $1,069,000 | +31.3% | 8,500 | +41.7% | 0.01% | +14.3% |
| Q4 2018 | $814,000 | -1.1% | 6,000 | +100.0% | 0.01% | +16.7% |
| Q3 2018 | $823,000 | +32.3% | 3,000 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $622,000 | -37.2% | 3,000 | -50.0% | 0.00% | -42.9% |
| Q1 2018 | $991,000 | +20.6% | 6,000 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $822,000 | +20.7% | 6,000 | +20.0% | 0.01% | +25.0% |
| Q3 2017 | $681,000 | +12.2% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $607,000 | +14.7% | 5,000 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $529,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |